Understanding how embryos communicate with their cells using chemical signals
Official title: Decoding the Spatial Grammar of Developmental Signaling
Funded at University of Pittsburgh at Pittsburgh · NIH-10687505 · Data updated 2026-11-12
This study is exploring how embryos use chemical signals to guide their cells, and it's designed to help scientists learn how to better direct stem cells to grow into specific tissues, which could eventually lead to new ways to create replacement tissues for medical treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project start | September 20, 2023 |
| Project end | August 31, 2026 |
| Funding year | 2023 |
| Award (this year) | $1,383,800 |
| NIH project number | 1DP2HD115158-01 |
| Project ID | NIH-10687505 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals interested in advancements in regenerative medicine, particularly those with conditions requiring tissue replacement or repair.
✕Less likely to help
Patients with conditions unrelated to tissue regeneration or those not seeking experimental therapies may not benefit from this research.
What this research studies
This research investigates the complex language of chemical signals that embryos use to instruct their cells. By developing new methods to create and test these signaling patterns, the project aims to enhance our understanding of how stem cells can be guided to form specific tissues. The approach utilizes high-throughput optogenetic manipulation, allowing researchers to control and observe signaling patterns in human stem cells with high precision. This innovative methodology could lead to breakthroughs in regenerative medicine by enabling the creation of replacement tissues in the lab.
Why it matters
Potential benefit: If successful, this research could revolutionize regenerative medicine by providing new ways to create and manipulate tissues for therapeutic purposes.
How similar studies have gone: Other research has shown promise in using optogenetic methods for manipulating cellular processes, indicating potential success for this novel approach.
Where this research is happening
-
University of Pittsburgh at Pittsburgh
Pittsburgh, United States Active
Researchers
- Principal investigator: Lord, Nathan Dale — University of Pittsburgh at Pittsburgh
- Study coordinator: Lord, Nathan Dale
Related research
Other NIH-funded projects on the same topics.
-
Elastomeric membranes for safer pelvic organ prolapse repair
A new 3D-printed elastomeric membrane made from polycarbonate urethane is being tested to replace stiff polypropylene meshes for pelvic organ prolapse in women, aiming to reduce complications.
-
Role of hyaluronan in egg development and ovarian reserve
This grant studies how the hyaluronan matrix in the ovary affects the aging of the female reproductive system and the pool of eggs available.
-
Regulatory switches that control imprinting in early human development
This grant studies how certain genes stay “one-copy” active in early development and what goes wrong in assisted reproduction, with a focus on imprinting disorders.
-
Identifying molecular signs of imprinting errors linked to fertility treatments
This grant studies how assisted reproductive technologies may cause imprinting errors in embryos and how these errors relate to certain birth conditions, with implications for families using infertility treatments.
-
Bioadhesive vaginal film for 7-day protection against HIV, HSV, and pregnancy
A vaginal film that slowly releases antibodies to prevent HIV, HSV, and unintended pregnancy for about a week from a single use.
-
Spermatogonial stem cell transplantation and culture in patients
Researchers are testing a way to transplant or grow sperm-producing cells back in boys and men who stored tissue before cancer treatment, to help them have biological children in the future.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.